Evaluation of partial least-squares with second-order advantage for the multi-way spectroscopic analysis of complex biological samples in the presence of analyte–background interactions

Literature Information

Publication Date 2006-04-11
DOI 10.1039/B603383K
Impact Factor 4.616
Authors

María J. Culzoni, Héctor C. Goicoechea, Ariana P. Pagani, Miguel A. Cabezón, Alejandro C. Olivieri


View Original

Abstract

The combination of unfolded partial least-squares (U-PLS) with residual bilinearization (RBL) has not been properly exploited to process experimental second-order spectroscopic information, although it is able to achieve the important second-order advantage. Among other desirable properties, the technique can handle incomplete calibration information, i.e., when only certain analyte concentrations are known in the training set. It can also cope with analyte spectral changes from sample to sample, due to its latent variable structure. In this work, U-PLS/RBL has been successfully applied to experimental fluorescence excitation–emission matrix data aimed at the quantitation of analytes in complex samples: these were the antibiotic tetracycline and the anti-inflammatory salicylate, in both cases in the presence of human serum, where significant analyte–background interactions occur. The interactions of the analyte with the serum proteins modify their spectral fluorescence properties, making it necessary to employ training sets of samples where the biological background is present, possibly causing analyte spectral changes from sample to sample. The predictive ability of the studied model has been compared with that of parallel factor analysis (PARAFAC), as regards test samples containing different sera, and also other pharmaceuticals which could act as potential interferents.

Related Literature

Elucidation of structure and nature of the PdO–Pd transformation using in situ PDF and XAS techniques

Jonathan Keating, Gopinathan Sankar, Timothy I. Hyde, Shinji Kohara, Koji Ohara

2013-04-26 Paper

DOI: 10.1039/C3CP50600B

Structure of Nb2O5–NaPO3 glasses by X-ray and neutron diffraction

U. Hoppe, L. Delevoye, L. Montagne, M. v. Zimmermann, A. C. Hannon

2012-12-03 Paper

DOI: 10.1039/C2CP42772A

Powder crystallography of pharmaceutical materials by combined crystal structure prediction and solid-state 1H NMR spectroscopy

Maria Baias, Cory M. Widdifield, Jean-Nicolas Dumez, Hugh P. G. Thompson, Timothy G. Cooper, Elodie Salager, Sirena Bassil, Robin S. Stein, Anne Lesage, Graeme M. Day, Lyndon Emsley

2013-02-19 Paper

DOI: 10.1039/C3CP41095A

Speciation of adsorbed CO2 on metal oxides by a new 2-dimensional approach: 2D infrared inversion spectroscopy (2D IRIS)

Sergey Sirotin, Philippe Bazin, Françoise Maugé, Arnaud Travert

2013-04-17 Paper

DOI: 10.1039/C3CP51146D

Assessment of density functional methods with correct asymptotic behavior

Chen-Wei Tsai, Yu-Chuan Su, Guan-De Li

2013-03-28 Paper

DOI: 10.1039/C3CP50441G

Field effect transistors and RC filters from pencil-trace on paper

Narendra Kurra, Dipanwita Dutta, Giridhar U. Kulkarni

2013-03-25 Paper

DOI: 10.1039/C3CP50675D

Chronoamperometric study of membrane electrode assembly operation in continuous flow photoelectrochemical water splitting

Jan Rongé, Dorien Nijs, Stef Kerkhofs, Kasper Masschaele, Johan A. Martens

2013-04-11 Paper

DOI: 10.1039/C3CP50890K

A time resolved high energy X-ray diffraction study of cooling liquid SiO2

C. J. Benmore, M. C. Wilding, S. K. Tumber

2013-04-05 Paper

DOI: 10.1039/C3CP44347G

New Li2FeSiO4–carbon monoliths with controlled macropores: effects of pore properties on electrode performance

George Hasegawa, Mai Sannohe, Yuya Ishihara, Kazuyoshi Kanamori, Kazuki Nakanishi, Takeshi Abe

2013-04-09 Paper

DOI: 10.1039/C3CP50352F

Back cover

Cover

DOI: 10.1039/C3CP90065G

You might also like

Compound Q&A

How should waste containing (6-Bromo-2-naphthyl)oxy](dimethyl)(2-methyl-2-propanyl)silane be handled?

Waste containing (6-Bromo-2-naphthyl)oxy](dimethyl)(2-methyl-2-propanyl)silane (...

100751-65-3[(6-Bromo-2-naphthyl...
Compound Q&A

How is 7-Fluoro-4-isoquinolinecarboxylic acid (CAS: 1841081-40-0) typically synthesized?

7-Fluoro-4-isoquinolinecarboxylic acid can be synthesized via a multi-step proce...

1841081-40-07-Fluoro-4-isoquinol...
Compound Q&A

What are the physical and chemical properties of 2,3,5,6-Tetrabromothieno[3,2-b]thiophene (CAS: 124638-53-5)?

2,3,5,6-Tetrabromothieno[3,2-b]thiophene is a crystalline compound with a high m...

124638-53-52,3,5,6-Tetrabromoth...
Compound Q&A

Is 1-[4-(Benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indole-4-carboxamide (CAS: 1542705-92-9) safe?

1-[4-(Benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indol...

1542705-92-91-[4-(Benzylamino)-7...
Compound Q&A

What is the market or research trend for imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylic acid, 3,4-dihydro-3-methyl-4-oxo- (CAS: 113942-30-6)?

The market for imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylic acid, 3,4-dihydro-3...

113942-30-6Imidazo[5,1-d]-1,2,3...
Compound Q&A

What is 3-(Triisopropylsilyl)propiolaldehyde (CAS: 163271-80-5)?

3-(Triisopropylsilyl)propiolaldehyde is a synthetic organic compound with the CA...

163271-80-53-(Triisopropylsilyl...
Compound Q&A

What regulatory guidelines apply to 6-Nitro-2H-1,4-benzoxazin-3(4H)-one (CAS: 81721-87-1)?

6-Nitro-2H-1,4-benzoxazin-3(4H)-one (CAS: 81721-87-1) is subject to various regu...

81721-87-16-Nitro-2H-1,4-benzo...
Compound Q&A

How should waste containing (3-Fluorophenyl)(4-{[(2-methyl-2-propanyl)oxy]carbonyl}-1-piperazinyl)acetic acid (CAS: 885272-91-3) be handled?

Waste containing (3-Fluorophenyl)(4-{[(2-methyl-2-propanyl)oxy]carbonyl}-1-piper...

885272-91-3(3-Fluorophenyl)(4-{...
Compound Q&A

What are the physical and chemical properties of N,N'-4,4'-Biphenyldiyldiisonicotinamide (CAS: 55119-40-9)?

N,N'-4,4'-Biphenyldiyldiisonicotinamide is a white crystalline solid with a mole...

55119-40-9N,N'-4,4'-Biphenyldi...
Compound Q&A

What industries use 6-Bromo-8-fluoro-2-quinazolinol (CAS: 1036756-15-6)?

6-Bromo-8-fluoro-2-quinazolinol is primarily used in the pharmaceutical industry...

1036756-15-66-Bromo-8-fluoro-2-q...

Source Journal

Analyst

Analyst
CiteScore: 7.8
Self-citation Rate: 5.6%
Articles per Year: 653

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.